New York, NY, United States of America

Norman E Keller

This inventor holds 1 USPTO granted patent. Top assignee: Enzo Biochem, Inc.. Active years: 2014.


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Norman E Keller in Therapeutic Compositions

Introduction

Norman E Keller is a notable inventor based in New York, NY (US). He has made significant contributions to the field of therapeutic and diagnostic compositions. His work focuses on enhancing biological functions and processing within cells through innovative chemical modifications.

Latest Patents

Keller holds a patent for "Property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses." This invention provides an array of compositions that are useful for effecting and/or exhibiting changes in biological functioning. The compositions combine chemical modifications and ligand additions with biological functions, enhancing their characteristics without substantially interfering with their biological roles. These enhancements include nuclease resistance and targeted interactions with specific cells or receptors.

Career Highlights

Keller is associated with Enzo Biochem, Inc., where he applies his expertise in developing advanced therapeutic solutions. His work has the potential to significantly impact the medical field by improving diagnostic and therapeutic processes.

Collaborations

Keller has collaborated with notable colleagues such as Elazar S Rabbani and Dakai Liu, contributing to the advancement of innovative solutions in the biochemistry sector.

Conclusion

Norman E Keller's contributions to therapeutic compositions exemplify the intersection of chemistry and biology, showcasing the potential for innovation in medical applications. His work continues to influence the development of effective therapeutic solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…